The safety risk of information overload and bureaucracy in oncology clinical trial conduct
-
Published:2023-04
Issue:
Volume:183
Page:90-94
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
van Ravensteijn Stefan G.ORCID,
Meijerink Mirte,
Nijenhuis-van Schayk Renée,
Desar Ingrid M.E.,
Bol Kalijn F.ORCID,
van Herpen Carla M.L.,
Verheul Henk M.W.ORCID
Subject
Cancer Research,Oncology
Reference28 articles.
1. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study;Arnold;Lancet Oncol,2019
2. Main changes in European clinical trials regulation (No 536/2014);Tenti;Contemp Clin Trials Commun,2018
3. Impact of cancer research bureaucracy on innovation, costs, and patient care;Steensma;J Clin Oncol,2014
4. Steps and time to process clinical trials at the cancer therapy evaluation program;Dilts;J Clin Oncol,2009
5. Information overload in the information age: a review of the literature from business administration, business psychology, and related disciplines with a bibliometric approach and framework development;Roetzel;Bus Res,2019